| Name | 4-oxo-1H-1,7-naphthyridine-3-carboxylic acid | 
|---|---|
| Synonyms | 
                                
                                4-oxo-1,4-dihydro-1,7-naphthyridine-3-carboxylic acid
                                
                                
                                 1,7-Naphthyridine-3-carboxylicacid,4-hydroxy 1,7-Naphthyridine-3-carboxylic acid, 4-hydroxy- 4-Hydroxy-1,7-naphthyridine-3-carboxylic acid  | 
                        
| Density | 1.6±0.1 g/cm3 | 
|---|---|
| Boiling Point | 423.2±45.0 °C at 760 mmHg | 
| Molecular Formula | C9H6N2O3 | 
| Molecular Weight | 190.156 | 
| Flash Point | 209.8±28.7 °C | 
| Exact Mass | 190.037842 | 
| PSA | 83.05000 | 
| LogP | 1.95 | 
| Vapour Pressure | 0.0±1.1 mmHg at 25°C | 
| Index of Refraction | 1.746 | 
| 
                                
                                
                                
                                
                                
                                
                                 ~%  
                                    92972-37-7  | 
                        
| Literature: VERTEX PHARMACEUTICALS INCORPORATED Patent: WO2009/36412 A1, 2009 ; Location in patent: Page/Page column 64-65 ; WO 2009/036412 A1 |